Article: 47 of Early-Stage Pharmaceutical Marketing Budgets Dedicated to Working With Thought Leaders.

RESEARCH TRIANGLE PARK, N.C., March 20 /PRNewswire/ -- Drug companies spend an average of 37 of their drug's marketing budgets on thought leader development, programs and activities in the early development stages, according to a new report, "Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch" (http://www.earlystagemarketing.com/), published by business intelligence firm Cutting Edge Information.

According to the report, 37 of marketing dollars spent during the pre-clinical stage, Phase I, and Phase II development support thought leader programs and activities. An additional 10 of overall commercialization spending goes toward developing new ...






Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!